Research in the News

Kaiser Permanente researchers show that patients being treated for cancer were much less likely to get severe COVID-19 if they received booster vaccinations against it.

Findings from a new Kaiser Permanente Northern California study can help physicians across the nation select the best treatment options for their patients.

First-of-a-kind Kaiser Permanente Northern California study sheds light on “cold drink heart,” a poorly understood condition.

Kaiser Permanente Northern California study reports on the impact of 13 years of annual outreach with at-home colorectal cancer testing.

One-year review of ambient scribe technology in The Permanente Medical Group finds evidence it could reduce documentation burden.

A unique Kaiser Permanente study confirms safety of using blood donated from people who have been vaccinated against or who have had COVID-19.

Kaiser Permanente Northern California study finds that telephone and video visits are a good option for kids, but not always a substitute for seeing a clinician in person.

A new study highlights the success of our comprehensive tobacco screening and cessation program over the past decade.

Study highlights new KP Northern California program that offers hereditary cancer testing to all newly diagnosed breast cancer patients ages 65 and under.

KP Northern California study found that new national recommendations to lower screening age from 50 to 45 can benefit patients and help identify cancer sooner.